Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance

Picard Medical announced a 1-for-50 reverse stock split effective July 31, 2026, to maintain NYSE American listing compliance. The split was approved by stockholders on July 17, 2026. The company, parent of SynCardia Systems (maker of the FDA and Health Canada-approved total artificial heart), aims to position itself for growth while advancing its next-generation Emperor platform.